Valeant CEO sees new drug pricing environment ahead

(Reuters) – Valeant Pharmaceuticals International Inc , which has been criticized for raising drug prices and is being investigated by the U.S. government, predicted on Monday that lower price increases are ahead for the whole industry.


START TYPING AND PRESS ENTER TO SEARCH